James P. Mackin - Feb 8, 2022 Form 4 Insider Report for ARTIVION, INC. (AORT)

Role
President & CEO
Signature
/s/ James P Mackin
Stock symbol
AORT
Transactions as of
Feb 8, 2022
Transactions value $
-$188,771
Form type
4
Date filed
2/10/2022, 06:53 AM
Previous filing
Feb 8, 2022
Next filing
Feb 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Options Exercise $117K +10.6K +3.5% $11.00 315K Feb 8, 2022 Direct F1
transaction AORT Common Stock Sale -$189K -10.6K -3.38% $17.75 304K Feb 8, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AORT StockOption(RightTo Buy) Options Exercise -$117K -10.6K -33.33% $11.00 21.3K Feb 8, 2022 Common Stock 10.6K $11.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021
F2 Reflects weighted average price. Range of prices were between $17.4 to $17.89. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016